Stonebridge Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.1M | Sell |
150,773
-3,981
| -3% | -$460K | 1.27% | 22 |
|
|
2025
Q4 | $16.3M | Buy |
154,754
+1,807
| +1% | +$170K | 1.13% | 29 |
|
|
2025
Q3 | $12.8M | Sell |
152,947
-130
| -0.1% | -$10.7K | 0.92% | 37 |
|
|
2025
Q2 | $12.1M | Sell |
153,077
-1,637
| -1% | -$130K | 0.92% | 38 |
|
|
2025
Q1 | $13.9M | Buy |
154,714
+7,570
| +5% | +$707K | 1.13% | 31 |
|
|
2024
Q4 | $14.6M | Buy |
147,144
+2,777
| +2% | +$286K | 1.18% | 28 |
|
|
2024
Q3 | $16.4M | Buy |
144,367
+7,612
| +6% | +$904K | 1.34% | 24 |
|
|
2024
Q2 | $16.9M | Buy |
136,755
+3,234
| +2% | +$417K | 1.49% | 20 |
|
|
2024
Q1 | $17.6M | Buy |
133,521
+5,212
| +4% | +$642K | 1.58% | 17 |
|
|
2023
Q4 | $14M | Buy |
128,309
+4,464
| +4% | +$463K | 1.4% | 18 |
|
|
2023
Q3 | $12.7M | Buy |
123,845
+1,901
| +2% | +$205K | 1.4% | 21 |
|
|
2023
Q2 | $14.1M | Sell |
121,944
-3,949
| -3% | -$448K | 1.49% | 17 |
|
|
2023
Q1 | $13.4M | Sell |
125,893
-792
| -0.6% | -$85.5K | 1.53% | 15 |
|
|
2022
Q4 | $14.1M | Sell |
126,685
-1,102
| -0.9% | -$113K | 1.67% | 13 |
|
|
2022
Q3 | $11M | Buy |
127,787
+525
| +0.4% | +$46.9K | 1.42% | 20 |
|
|
2022
Q2 | $11.6M | Sell |
127,262
-611
| -0.5% | -$54.2K | 1.41% | 18 |
|
|
2022
Q1 | $10.5M | Buy |
127,873
+5,565
| +5% | +$439K | 1.13% | 33 |
|
|
2021
Q4 | $9.37M | Buy |
122,308
+1,519
| +1% | +$121K | 1.04% | 38 |
|
|
2021
Q3 | $9.07M | Sell |
120,789
-99,100
| -45% | -$7.54M | 1.1% | 35 |
|
|
2021
Q2 | $17M | Buy |
219,889
+109,145
| +99% | +$8.12M | 1.08% | 36 |
|
|
2021
Q1 | $8.15M | Buy |
110,744
+11,063
| +11% | +$816K | 1.08% | 36 |
|
|
2020
Q4 | $7.78M | Buy |
99,681
+4,551
| +5% | +$348K | 1.18% | 31 |
|
|
2020
Q3 | $7.53M | Buy |
95,130
+2,322
| +3% | +$182K | 1.35% | 27 |
|
|
2020
Q2 | $6.85M | Buy |
92,808
+1,301
| +1% | +$97.9K | 1.27% | 27 |
|
|
2020
Q1 | $6.72M | Buy |
91,507
+8,134
| +10% | +$639K | 1.42% | 19 |
|
|
2019
Q4 | $7.24M | Sell |
83,373
-1,948
| -2% | -$160K | 1.18% | 30 |
|
|
2019
Q3 | $6.85M | Sell |
85,321
-1,664
| -2% | -$133K | 1.18% | 29 |
|
|
2019
Q2 | $6.96M | Sell |
86,985
-4,334
| -5% | -$332K | 1.24% | 27 |
|
|
2019
Q1 | $7.25M | Buy |
91,319
+410
| +0.5% | +$30.7K | 1.35% | 24 |
|
|
2018
Q4 | $6.63M | Sell |
90,909
-1,425
| -2% | -$101K | 1.55% | 20 |
|
|
2018
Q3 | $6.25M | Buy |
92,334
+534
| +0.6% | +$34K | 1.26% | 29 |
|
|
2018
Q2 | $5.32M | Buy |
91,800
+2,705
| +3% | +$153K | 1.16% | 34 |
|
|
2018
Q1 | $4.63M | Buy |
89,095
+4,661
| +6% | +$252K | 1.07% | 35 |
|
|
2017
Q4 | $4.53M | Buy |
84,434
+5,147
| +6% | +$285K | 1.04% | 37 |
|
|
2017
Q3 | $4.84M | Buy |
79,287
+4,526
| +6% | +$274K | 1.19% | 27 |
|
|
2017
Q2 | $4.57M | Buy |
74,761
+2,000
| +3% | +$122K | 1.2% | 25 |
|
|
2017
Q1 | $4.41M | Buy |
72,761
+2,058
| +3% | +$125K | 1.2% | 24 |
|
|
2016
Q4 | $3.97M | Buy |
70,703
+3,396
| +5% | +$199K | 1.18% | 28 |
|
|
2016
Q3 | $4.01M | Buy |
67,307
+2,803
| +4% | +$164K | 1.25% | 20 |
|
|
2016
Q2 | $3.55M | Buy |
64,504
+5,166
| +9% | +$275K | 1.2% | 25 |
|
|
2016
Q1 | $3M | Buy |
59,338
+2,438
| +4% | +$119K | 1.06% | 32 |
|
|
2015
Q4 | $2.87M | Buy |
56,900
+5,451
| +11% | +$275K | 1.05% | 33 |
|
|
2015
Q3 | $2.42M | Buy |
51,449
+2,955
| +6% | +$157K | 0.98% | 35 |
|
|
2015
Q2 | $2.63M | Buy |
48,494
+3,176
| +7% | +$178K | 1.01% | 38 |
|
|
2015
Q1 | $2.49M | Buy |
45,318
+6,365
| +16% | +$360K | 0.96% | 41 |
|
|
2014
Q4 | $2.11M | Buy |
38,953
+367
| +1% | +$20.4K | 0.87% | 43 |
|
|
2014
Q3 | $2.18M | Buy |
38,586
+999
| +3% | +$56.1K | 0.96% | 39 |
|
|
2014
Q2 | $2.08M | Buy |
37,587
+1,734
| +5% | +$94.6K | 0.94% | 40 |
|
|
2014
Q1 | $1.94M | Buy |
35,853
+1,948
| +6% | +$101K | 0.95% | 41 |
|
|
2013
Q4 | $1.62M | Buy |
+33,905
| New | +$1.55M | 0.83% | 46 |
|
Other funds holding MRK
VCM
VPM
Stonebridge Capital Advisors's MRK Position: Q1 2026 in Review
Stonebridge Capital Advisors reduced its Merck (MRK) stake by 2.6% in Q1 2026, selling an estimated $460K and leaving 150,773 shares worth $18.1M. The position accounts for 1.27% of the portfolio, ranked #22.
Stonebridge Capital Advisors first reported a position in MRK in Q4 2013 and has held it in 50 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Stonebridge Capital Advisors held 150,773 shares of Merck worth $18.1M as of Q1 2026.
- Stonebridge Capital Advisors sold 3,981 Merck shares in Q1 2026, an estimated $460K.
- Merck made up 1.27% of Stonebridge Capital Advisors's portfolio in Q1 2026, its #22 holding.
- Stonebridge Capital Advisors first reported a position in Merck in Q4 2013 and has held it in 50 quarters since.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Stonebridge Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.